The future of PTSD care is increasingly shaped by advances in interventional psychiatry research that look beyond symptom suppression and toward core brain mechanisms. A recent review on active forgetting neurostimulation PTSD reframes trauma as a disorder of impaired forgetting rather than excessive remembering, offering a novel therapeutic target rooted in neuroscience rather than phenomenology.
Post-traumatic stress disorder has long been treated through approaches that aim to dampen emotional reactivity, enhance coping skills, or reconsolidate traumatic memories through psychotherapy. While these strategies can be effective for many patients, intrusive memories often persist, suggesting that existing treatments may not fully address the underlying neurobiology of memory persistence.
Current Standards Struggle To Address Pathological Memory Persistence
Traditional PTSD treatments primarily focus on fear extinction, emotional regulation, and cognitive restructuring. These methods assume that traumatic memories are too strong or emotionally charged. However, growing evidence suggests that the deeper issue may be a failure of the brain’s active forgetting systems. In healthy individuals, forgetting is not passive decay but a regulated process that suppresses irrelevant or harmful memories.
When this system fails, traumatic memories remain vivid, intrusive, and easily triggered. This reframing helps explain why some patients continue to experience flashbacks despite successful therapy engagement and medication adherence.
Introducing Active Forgetting As A Therapeutic Target
Active forgetting neurostimulation PTSD research proposes that memory suppression is driven by coordinated activity between the hippocampus and prefrontal cortex. These regions interact to inhibit retrieval of memories that are no longer adaptive. Neurotransmitters such as dopamine, glutamate, and GABA appear to regulate this process at a circuit level.
By targeting these circuits directly, researchers suggest it may be possible to restore adaptive forgetting rather than repeatedly revisiting traumatic content. This represents a shift from memory modification toward memory regulation.
Why The Model Of Active Forgetting Matters
The review emphasizes that active forgetting is distinct from extinction or reconsolidation. Extinction overlays new learning on top of existing memories, while reconsolidation modifies memory content. Active forgetting, in contrast, reduces the accessibility of memories altogether.
This distinction matters clinically because intrusive memories are often experienced as involuntary and uncontrollable. Interventions that reduce retrieval likelihood may therefore offer relief without requiring repeated trauma exposure.
Key Findings From Active Forgetting Neurostimulation PTSD Research
Non-invasive neurostimulation methods such as transcranial magnetic stimulation, transcranial direct current stimulation, and transcranial ultrasound stimulation have been shown to influence hippocampal prefrontal connectivity. Early studies suggest these techniques can modulate memory salience, retrieval strength, and emotional tagging.
While much of the evidence remains preclinical or early-phase, results consistently point toward the feasibility of externally influencing forgetting-related circuits in a controlled manner.
How Neurostimulation May Support Adaptive Forgetting
TMS and ultrasound stimulation can alter cortical excitability and network synchronization. When applied to prefrontal regions involved in inhibitory control, these modalities may enhance top-down suppression of traumatic memory retrieval. Ultrasound offers additional promise due to its ability to reach deeper brain structures with spatial precision.
Rather than erasing memories, these approaches aim to restore balance between remembering and forgetting, allowing patients to access memories voluntarily without being overwhelmed by them.
What Makes This Framework Distinct
Unlike many PTSD models, this approach integrates cognitive neuroscience, molecular signaling, and neurotechnology into a unified framework. It positions forgetting as a skill that can be rehabilitated rather than a deficit to be compensated for.
Importantly, it also opens the door to personalized interventions based on circuit-level dysfunction rather than symptom clusters alone.
Clinical Implications And Future Directions
If validated in larger trials, active forgetting neurostimulation PTSD strategies could complement psychotherapy and pharmacology rather than replace them. Neurostimulation sessions might be paired with therapy to reinforce adaptive memory suppression during recovery.
The authors highlight key unanswered questions, including optimal stimulation targets, dosing schedules, and long-term effects. Addressing these gaps will be essential before widespread clinical adoption.
A Measured Path Forward
This work represents a conceptual advance rather than a ready-made treatment. However, by shifting attention toward the biology of forgetting, it provides a compelling roadmap for next-generation PTSD interventions that aim to resolve trauma at its neurological roots.
Citations
Arulchelvan E, Vanneste S. Targeting active forgetting with non-invasive stimulation toward novel treatments for intrusive memories in PTSD. Journal of Mental Health. 2026. https://doi.org/10.1080/09540261.2026.2631028Mary A, Dayan J, Leone G, et al. Resilience after trauma from a neurobiological perspective. Neuroscience and Biobehavioral Reviews. 2020. https://doi.org/10.1016/j.neubiorev.2019.12.006
Explore more at Interventional Psychiatry News to learn more about the future of mental health therapies.